Molecular Assays

MarketReports.com | Pharmaceuticals & Healthcare | Diagnostics | In Vitro Diagnostics |  Molecular Assays

Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: Aug-2011 Format: PDF Pages: 278 Publisher: MarketsandMarkets Table of Contents A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on a solid platform that allows multiple tests to be performed at the same time with increased efficiency and higher speed. The global biochip market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 billion by 2015; growing at a CAGR of 16.7%. This growth is attributed to increasing applications in cancer diagnostics and expression profiling, the boom in personalized medicine, and government funding. More...

Global DNA & Gene Chip (Microarray) Market (2010 - 2015) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: May-2011 Format: PDF Pages: 331 Publisher: MarketsandMarkets Table of Contents Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010. Gene Expression currently forms the largest application market as gene expression products are used in a wide variety of research activities including life sciences research, clinical diagnostics, biodefense, and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis and treatment application is expected to dominate the applications market by 2015; accounting for about 24% share in the market. More...

MarketReports.com | Pharmaceuticals & Healthcare | Diagnostics | In Vitro Diagnostics |  Molecular Assays